Reagan Parr, MD
Orthopaedic Surgery · Johnson City, TNNPI 1750351458
Payments from drug & device makers
Across 29 payments — averaging $16.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ferring Pharmaceuticals Inc.$147
- Pacira Therapeutics, Inc.$109
- Linvatec Corporation$65
- Johnson & Johnson$52
- Acell, Inc.$25
- Innovation Technologies Inc$18
- plus $64 from 5 others
What the payments were for
- Food & beverage$479100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 10 | $147 |
| Pacira Therapeutics, Inc. | 8 | $109 |
| Linvatec Corporation | 2 | $65 |
| Johnson & Johnson(2 entities) | 2 | $52 |
| Acell, Inc. | 1 | $25 |
| Innovation Technologies Inc | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Tactile Systems Technology Inc | 1 | $13 |
| AstraZeneca | 1 | $13 |
| Endo Pharmaceuticals Inc. | 1 | $12 |
| Zyla Life Sciences, Inc. | 1 | $12 |
How this compares
$479 in reported general payments places this provider in the 20th percentile of 381 orthopaedic surgery providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 46 | $963 |
| Ibuprofen | 63 | $564 |
| Gabapentin | 12 | $214 |
| Meloxicam | 42 | $167 |
| Promethazine Hcl | 24 | $98 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Johnson City
- Scott MacdonaldJohnson City$114K
- Thomas HuddlestonJohnson City$59K
- Larry WaldropJohnson City$45K
- Alan AikenJohnson City$45K
- Paul BradyKnoxville$20.1M
- Jesse DotyChattanooga$2.5M
- Edwin SpencerKnoxville$2.5M
- Thomas ThrockmortonGermantown$1.9M
- Tyler BrolinCollierville$1M
- Jefferson MorrisonNashville$910K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.